Hyponatraemia compounding pre-eclamptic toxaemia in a patient with type 1 diabetes

BMJ Case Rep. 2020 Sep 2;13(9):e236511. doi: 10.1136/bcr-2020-236511.

Abstract

We report a case of profound, symptomatic hyponatraemia in association with pre-eclamptic toxaemia (PET) in a 38-year-old nulliparous woman with type 1 diabetes mellitus. This patient developed hypertension and proteinuria at 31+6 weeks' gestation and was admitted for management of pre-eclampsia. Severe headache, visual disturbance and nausea were associated with a hyponatraemia of 115 mmol/L followed by ketoacidosis. This was reversed through fluid restriction, supplementation with 1.8%-3.0% hypertonic saline and a volume-reduced variable-rate insulin infusion. Clinical stability was achieved and she was subsequently worked up for an induction of labour for worsening pre-eclampsia. Hyponatraemia in the context of PET has been previously reported as rare. However, it has complications that may significantly compound the sequelae of severe PET. We propose that specific and focused monitoring of serum sodium levels should become common practice in the management of women with this condition to allow for timely, measured correction of abnormalities.

Keywords: diabetes; endocrinology; obstetrics and gynaecology.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetes Mellitus, Type 1 / drug therapy
  • Female
  • Humans
  • Hyponatremia / blood
  • Hyponatremia / diagnosis*
  • Hyponatremia / etiology
  • Hyponatremia / therapy
  • Insulin / administration & dosage
  • Pre-Eclampsia / blood
  • Pre-Eclampsia / diagnosis*
  • Pre-Eclampsia / therapy
  • Pregnancy
  • Saline Solution, Hypertonic / administration & dosage
  • Severity of Illness Index
  • Toxemia / blood
  • Toxemia / diagnosis*
  • Toxemia / etiology
  • Toxemia / therapy
  • Treatment Outcome

Substances

  • Insulin
  • Saline Solution, Hypertonic